+1 (704) 266-3234

Global Intranasal Drug Delivery System Market Growth 2022-2028

Published on: May 2022 | From USD $2900 | Published By: LP INFORMATION INC | Number Of Pages: 102

As the global economy mends, the 2021 growth of Intranasal Drug Delivery System will have significant change from previous year. According to our latest study, the global Intranasal Drug Delivery System market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Intranasal Drug Delivery System market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Intranasal Drug Delivery System market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Intranasal Drug Delivery System market, reaching US$ million by the year 2028. As for the Europe Intranasal Drug Delivery System landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Intranasal Drug Delivery System players cover Aptar Pharma, Nemera, Teleflex, and Mystic Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Intranasal Drug Delivery System market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Nasal Drops
Nasal Sprays
Nasal Gels
Nasal Suspensions and Emulsion
Nasal Powders
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Home Care
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Aptar Pharma
Nemera
Teleflex
Mystic Pharmaceuticals
Zeteo Medical
Johnson & Johnson
GlaxoSmithKline Plc
Aegis Therapeutics LLC
H&T Presspart Manufacturing Ltd.
AstraZeneca Plc
Becton
BD
Novartis AG
Vectura Group Plc

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intranasal Drug Delivery System Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Intranasal Drug Delivery System by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Intranasal Drug Delivery System by Country/Region, 2017, 2022 & 2028
2.2 Intranasal Drug Delivery System Segment by Type
2.2.1 Nasal Drops
2.2.2 Nasal Sprays
2.2.3 Nasal Gels
2.2.4 Nasal Suspensions and Emulsion
2.2.5 Nasal Powders
2.3 Intranasal Drug Delivery System Sales by Type
2.3.1 Global Intranasal Drug Delivery System Sales Market Share by Type (2017-2022)
2.3.2 Global Intranasal Drug Delivery System Revenue and Market Share by Type (2017-2022)
2.3.3 Global Intranasal Drug Delivery System Sale Price by Type (2017-2022)
2.4 Intranasal Drug Delivery System Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Home Care
2.4.4 Others
2.5 Intranasal Drug Delivery System Sales by Application
2.5.1 Global Intranasal Drug Delivery System Sale Market Share by Application (2017-2022)
2.5.2 Global Intranasal Drug Delivery System Revenue and Market Share by Application (2017-2022)
2.5.3 Global Intranasal Drug Delivery System Sale Price by Application (2017-2022)
3 Global Intranasal Drug Delivery System by Company
3.1 Global Intranasal Drug Delivery System Breakdown Data by Company
3.1.1 Global Intranasal Drug Delivery System Annual Sales by Company (2020-2022)
3.1.2 Global Intranasal Drug Delivery System Sales Market Share by Company (2020-2022)
3.2 Global Intranasal Drug Delivery System Annual Revenue by Company (2020-2022)
3.2.1 Global Intranasal Drug Delivery System Revenue by Company (2020-2022)
3.2.2 Global Intranasal Drug Delivery System Revenue Market Share by Company (2020-2022)
3.3 Global Intranasal Drug Delivery System Sale Price by Company
3.4 Key Manufacturers Intranasal Drug Delivery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intranasal Drug Delivery System Product Location Distribution
3.4.2 Players Intranasal Drug Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Intranasal Drug Delivery System by Geographic Region
4.1 World Historic Intranasal Drug Delivery System Market Size by Geographic Region (2017-2022)
4.1.1 Global Intranasal Drug Delivery System Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Intranasal Drug Delivery System Annual Revenue by Geographic Region
4.2 World Historic Intranasal Drug Delivery System Market Size by Country/Region (2017-2022)
4.2.1 Global Intranasal Drug Delivery System Annual Sales by Country/Region (2017-2022)
4.2.2 Global Intranasal Drug Delivery System Annual Revenue by Country/Region
4.3 Americas Intranasal Drug Delivery System Sales Growth
4.4 APAC Intranasal Drug Delivery System Sales Growth
4.5 Europe Intranasal Drug Delivery System Sales Growth
4.6 Middle East & Africa Intranasal Drug Delivery System Sales Growth
5 Americas
5.1 Americas Intranasal Drug Delivery System Sales by Country
5.1.1 Americas Intranasal Drug Delivery System Sales by Country (2017-2022)
5.1.2 Americas Intranasal Drug Delivery System Revenue by Country (2017-2022)
5.2 Americas Intranasal Drug Delivery System Sales by Type
5.3 Americas Intranasal Drug Delivery System Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intranasal Drug Delivery System Sales by Region
6.1.1 APAC Intranasal Drug Delivery System Sales by Region (2017-2022)
6.1.2 APAC Intranasal Drug Delivery System Revenue by Region (2017-2022)
6.2 APAC Intranasal Drug Delivery System Sales by Type
6.3 APAC Intranasal Drug Delivery System Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intranasal Drug Delivery System by Country
7.1.1 Europe Intranasal Drug Delivery System Sales by Country (2017-2022)
7.1.2 Europe Intranasal Drug Delivery System Revenue by Country (2017-2022)
7.2 Europe Intranasal Drug Delivery System Sales by Type
7.3 Europe Intranasal Drug Delivery System Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intranasal Drug Delivery System by Country
8.1.1 Middle East & Africa Intranasal Drug Delivery System Sales by Country (2017-2022)
8.1.2 Middle East & Africa Intranasal Drug Delivery System Revenue by Country (2017-2022)
8.2 Middle East & Africa Intranasal Drug Delivery System Sales by Type
8.3 Middle East & Africa Intranasal Drug Delivery System Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intranasal Drug Delivery System
10.3 Manufacturing Process Analysis of Intranasal Drug Delivery System
10.4 Industry Chain Structure of Intranasal Drug Delivery System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intranasal Drug Delivery System Distributors
11.3 Intranasal Drug Delivery System Customer
12 World Forecast Review for Intranasal Drug Delivery System by Geographic Region
12.1 Global Intranasal Drug Delivery System Market Size Forecast by Region
12.1.1 Global Intranasal Drug Delivery System Forecast by Region (2023-2028)
12.1.2 Global Intranasal Drug Delivery System Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intranasal Drug Delivery System Forecast by Type
12.7 Global Intranasal Drug Delivery System Forecast by Application
13 Key Players Analysis
13.1 Aptar Pharma
13.1.1 Aptar Pharma Company Information
13.1.2 Aptar Pharma Intranasal Drug Delivery System Product Offered
13.1.3 Aptar Pharma Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Aptar Pharma Main Business Overview
13.1.5 Aptar Pharma Latest Developments
13.2 Nemera
13.2.1 Nemera Company Information
13.2.2 Nemera Intranasal Drug Delivery System Product Offered
13.2.3 Nemera Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Nemera Main Business Overview
13.2.5 Nemera Latest Developments
13.3 Teleflex
13.3.1 Teleflex Company Information
13.3.2 Teleflex Intranasal Drug Delivery System Product Offered
13.3.3 Teleflex Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teleflex Main Business Overview
13.3.5 Teleflex Latest Developments
13.4 Mystic Pharmaceuticals
13.4.1 Mystic Pharmaceuticals Company Information
13.4.2 Mystic Pharmaceuticals Intranasal Drug Delivery System Product Offered
13.4.3 Mystic Pharmaceuticals Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Mystic Pharmaceuticals Main Business Overview
13.4.5 Mystic Pharmaceuticals Latest Developments
13.5 Zeteo Medical
13.5.1 Zeteo Medical Company Information
13.5.2 Zeteo Medical Intranasal Drug Delivery System Product Offered
13.5.3 Zeteo Medical Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zeteo Medical Main Business Overview
13.5.5 Zeteo Medical Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Intranasal Drug Delivery System Product Offered
13.6.3 Johnson & Johnson Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 GlaxoSmithKline Plc
13.7.1 GlaxoSmithKline Plc Company Information
13.7.2 GlaxoSmithKline Plc Intranasal Drug Delivery System Product Offered
13.7.3 GlaxoSmithKline Plc Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 GlaxoSmithKline Plc Main Business Overview
13.7.5 GlaxoSmithKline Plc Latest Developments
13.8 Aegis Therapeutics LLC
13.8.1 Aegis Therapeutics LLC Company Information
13.8.2 Aegis Therapeutics LLC Intranasal Drug Delivery System Product Offered
13.8.3 Aegis Therapeutics LLC Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Aegis Therapeutics LLC Main Business Overview
13.8.5 Aegis Therapeutics LLC Latest Developments
13.9 H&T Presspart Manufacturing Ltd.
13.9.1 H&T Presspart Manufacturing Ltd. Company Information
13.9.2 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Product Offered
13.9.3 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 H&T Presspart Manufacturing Ltd. Main Business Overview
13.9.5 H&T Presspart Manufacturing Ltd. Latest Developments
13.10 AstraZeneca Plc
13.10.1 AstraZeneca Plc Company Information
13.10.2 AstraZeneca Plc Intranasal Drug Delivery System Product Offered
13.10.3 AstraZeneca Plc Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 AstraZeneca Plc Main Business Overview
13.10.5 AstraZeneca Plc Latest Developments
13.11 Becton
13.11.1 Becton Company Information
13.11.2 Becton Intranasal Drug Delivery System Product Offered
13.11.3 Becton Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Becton Main Business Overview
13.11.5 Becton Latest Developments
13.12 BD
13.12.1 BD Company Information
13.12.2 BD Intranasal Drug Delivery System Product Offered
13.12.3 BD Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 BD Main Business Overview
13.12.5 BD Latest Developments
13.13 Novartis AG
13.13.1 Novartis AG Company Information
13.13.2 Novartis AG Intranasal Drug Delivery System Product Offered
13.13.3 Novartis AG Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Novartis AG Main Business Overview
13.13.5 Novartis AG Latest Developments
13.14 Vectura Group Plc
13.14.1 Vectura Group Plc Company Information
13.14.2 Vectura Group Plc Intranasal Drug Delivery System Product Offered
13.14.3 Vectura Group Plc Intranasal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Vectura Group Plc Main Business Overview
13.14.5 Vectura Group Plc Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Intranasal Drug Delivery System Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Intranasal Drug Delivery System Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Nasal Drops
Table 4. Major Players of Nasal Sprays
Table 5. Major Players of Nasal Gels
Table 6. Major Players of Nasal Suspensions and Emulsion
Table 7. Major Players of Nasal Powders
Table 8. Global Intranasal Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 9. Global Intranasal Drug Delivery System Sales Market Share by Type (2017-2022)
Table 10. Global Intranasal Drug Delivery System Revenue by Type (2017-2022) & ($ million)
Table 11. Global Intranasal Drug Delivery System Revenue Market Share by Type (2017-2022)
Table 12. Global Intranasal Drug Delivery System Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Intranasal Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 14. Global Intranasal Drug Delivery System Sales Market Share by Application (2017-2022)
Table 15. Global Intranasal Drug Delivery System Revenue by Application (2017-2022)
Table 16. Global Intranasal Drug Delivery System Revenue Market Share by Application (2017-2022)
Table 17. Global Intranasal Drug Delivery System Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Intranasal Drug Delivery System Sales by Company (2020-2022) & (K Units)
Table 19. Global Intranasal Drug Delivery System Sales Market Share by Company (2020-2022)
Table 20. Global Intranasal Drug Delivery System Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Intranasal Drug Delivery System Revenue Market Share by Company (2020-2022)
Table 22. Global Intranasal Drug Delivery System Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Intranasal Drug Delivery System Producing Area Distribution and Sales Area
Table 24. Players Intranasal Drug Delivery System Products Offered
Table 25. Intranasal Drug Delivery System Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Intranasal Drug Delivery System Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Intranasal Drug Delivery System Sales Market Share Geographic Region (2017-2022)
Table 30. Global Intranasal Drug Delivery System Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Intranasal Drug Delivery System Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Intranasal Drug Delivery System Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Intranasal Drug Delivery System Sales Market Share by Country/Region (2017-2022)
Table 34. Global Intranasal Drug Delivery System Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Intranasal Drug Delivery System Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Intranasal Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 37. Americas Intranasal Drug Delivery System Sales Market Share by Country (2017-2022)
Table 38. Americas Intranasal Drug Delivery System Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Intranasal Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 40. Americas Intranasal Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 41. Americas Intranasal Drug Delivery System Sales Market Share by Type (2017-2022)
Table 42. Americas Intranasal Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 43. Americas Intranasal Drug Delivery System Sales Market Share by Application (2017-2022)
Table 44. APAC Intranasal Drug Delivery System Sales by Region (2017-2022) & (K Units)
Table 45. APAC Intranasal Drug Delivery System Sales Market Share by Region (2017-2022)
Table 46. APAC Intranasal Drug Delivery System Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Intranasal Drug Delivery System Revenue Market Share by Region (2017-2022)
Table 48. APAC Intranasal Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 49. APAC Intranasal Drug Delivery System Sales Market Share by Type (2017-2022)
Table 50. APAC Intranasal Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 51. APAC Intranasal Drug Delivery System Sales Market Share by Application (2017-2022)
Table 52. Europe Intranasal Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 53. Europe Intranasal Drug Delivery System Sales Market Share by Country (2017-2022)
Table 54. Europe Intranasal Drug Delivery System Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Intranasal Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 56. Europe Intranasal Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 57. Europe Intranasal Drug Delivery System Sales Market Share by Type (2017-2022)
Table 58. Europe Intranasal Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 59. Europe Intranasal Drug Delivery System Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Intranasal Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Intranasal Drug Delivery System Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Intranasal Drug Delivery System Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Intranasal Drug Delivery System Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Intranasal Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Intranasal Drug Delivery System Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Intranasal Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Intranasal Drug Delivery System Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Intranasal Drug Delivery System
Table 69. Key Market Challenges & Risks of Intranasal Drug Delivery System
Table 70. Key Industry Trends of Intranasal Drug Delivery System
Table 71. Intranasal Drug Delivery System Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Intranasal Drug Delivery System Distributors List
Table 74. Intranasal Drug Delivery System Customer List
Table 75. Global Intranasal Drug Delivery System Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Intranasal Drug Delivery System Sales Market Forecast by Region
Table 77. Global Intranasal Drug Delivery System Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Intranasal Drug Delivery System Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Intranasal Drug Delivery System Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Intranasal Drug Delivery System Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Intranasal Drug Delivery System Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Intranasal Drug Delivery System Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Intranasal Drug Delivery System Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Intranasal Drug Delivery System Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Intranasal Drug Delivery System Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Intranasal Drug Delivery System Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Intranasal Drug Delivery System Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Intranasal Drug Delivery System Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Intranasal Drug Delivery System Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Intranasal Drug Delivery System Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Intranasal Drug Delivery System Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Intranasal Drug Delivery System Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Intranasal Drug Delivery System Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Intranasal Drug Delivery System Revenue Market Share Forecast by Application (2023-2028)
Table 95. Aptar Pharma Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 96. Aptar Pharma Intranasal Drug Delivery System Product Offered
Table 97. Aptar Pharma Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. Aptar Pharma Main Business
Table 99. Aptar Pharma Latest Developments
Table 100. Nemera Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 101. Nemera Intranasal Drug Delivery System Product Offered
Table 102. Nemera Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Nemera Main Business
Table 104. Nemera Latest Developments
Table 105. Teleflex Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 106. Teleflex Intranasal Drug Delivery System Product Offered
Table 107. Teleflex Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Teleflex Main Business
Table 109. Teleflex Latest Developments
Table 110. Mystic Pharmaceuticals Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 111. Mystic Pharmaceuticals Intranasal Drug Delivery System Product Offered
Table 112. Mystic Pharmaceuticals Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Mystic Pharmaceuticals Main Business
Table 114. Mystic Pharmaceuticals Latest Developments
Table 115. Zeteo Medical Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 116. Zeteo Medical Intranasal Drug Delivery System Product Offered
Table 117. Zeteo Medical Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Zeteo Medical Main Business
Table 119. Zeteo Medical Latest Developments
Table 120. Johnson & Johnson Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 121. Johnson & Johnson Intranasal Drug Delivery System Product Offered
Table 122. Johnson & Johnson Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Johnson & Johnson Main Business
Table 124. Johnson & Johnson Latest Developments
Table 125. GlaxoSmithKline Plc Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 126. GlaxoSmithKline Plc Intranasal Drug Delivery System Product Offered
Table 127. GlaxoSmithKline Plc Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. GlaxoSmithKline Plc Main Business
Table 129. GlaxoSmithKline Plc Latest Developments
Table 130. Aegis Therapeutics LLC Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 131. Aegis Therapeutics LLC Intranasal Drug Delivery System Product Offered
Table 132. Aegis Therapeutics LLC Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Aegis Therapeutics LLC Main Business
Table 134. Aegis Therapeutics LLC Latest Developments
Table 135. H&T Presspart Manufacturing Ltd. Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 136. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Product Offered
Table 137. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. H&T Presspart Manufacturing Ltd. Main Business
Table 139. H&T Presspart Manufacturing Ltd. Latest Developments
Table 140. AstraZeneca Plc Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 141. AstraZeneca Plc Intranasal Drug Delivery System Product Offered
Table 142. AstraZeneca Plc Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. AstraZeneca Plc Main Business
Table 144. AstraZeneca Plc Latest Developments
Table 145. Becton Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 146. Becton Intranasal Drug Delivery System Product Offered
Table 147. Becton Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. Becton Main Business
Table 149. Becton Latest Developments
Table 150. BD Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 151. BD Intranasal Drug Delivery System Product Offered
Table 152. BD Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. BD Main Business
Table 154. BD Latest Developments
Table 155. Novartis AG Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 156. Novartis AG Intranasal Drug Delivery System Product Offered
Table 157. Novartis AG Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 158. Novartis AG Main Business
Table 159. Novartis AG Latest Developments
Table 160. Vectura Group Plc Basic Information, Intranasal Drug Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 161. Vectura Group Plc Intranasal Drug Delivery System Product Offered
Table 162. Vectura Group Plc Intranasal Drug Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 163. Vectura Group Plc Main Business
Table 164. Vectura Group Plc Latest Developments
List of Figures
Figure 1. Picture of Intranasal Drug Delivery System
Figure 2. Intranasal Drug Delivery System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intranasal Drug Delivery System Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Intranasal Drug Delivery System Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Intranasal Drug Delivery System Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Nasal Drops
Figure 10. Product Picture of Nasal Sprays
Figure 11. Product Picture of Nasal Gels
Figure 12. Product Picture of Nasal Suspensions and Emulsion
Figure 13. Product Picture of Nasal Powders
Figure 14. Global Intranasal Drug Delivery System Sales Market Share by Type in 2021
Figure 15. Global Intranasal Drug Delivery System Revenue Market Share by Type (2017-2022)
Figure 16. Intranasal Drug Delivery System Consumed in Hospital
Figure 17. Global Intranasal Drug Delivery System Market: Hospital (2017-2022) & (K Units)
Figure 18. Intranasal Drug Delivery System Consumed in Clinic
Figure 19. Global Intranasal Drug Delivery System Market: Clinic (2017-2022) & (K Units)
Figure 20. Intranasal Drug Delivery System Consumed in Home Care
Figure 21. Global Intranasal Drug Delivery System Market: Home Care (2017-2022) & (K Units)
Figure 22. Intranasal Drug Delivery System Consumed in Others
Figure 23. Global Intranasal Drug Delivery System Market: Others (2017-2022) & (K Units)
Figure 24. Global Intranasal Drug Delivery System Sales Market Share by Application (2017-2022)
Figure 25. Global Intranasal Drug Delivery System Revenue Market Share by Application in 2021
Figure 26. Intranasal Drug Delivery System Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Intranasal Drug Delivery System Revenue Market Share by Company in 2021
Figure 28. Global Intranasal Drug Delivery System Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Intranasal Drug Delivery System Revenue Market Share by Geographic Region in 2021
Figure 30. Global Intranasal Drug Delivery System Sales Market Share by Region (2017-2022)
Figure 31. Global Intranasal Drug Delivery System Revenue Market Share by Country/Region in 2021
Figure 32. Americas Intranasal Drug Delivery System Sales 2017-2022 (K Units)
Figure 33. Americas Intranasal Drug Delivery System Revenue 2017-2022 ($ Millions)
Figure 34. APAC Intranasal Drug Delivery System Sales 2017-2022 (K Units)
Figure 35. APAC Intranasal Drug Delivery System Revenue 2017-2022 ($ Millions)
Figure 36. Europe Intranasal Drug Delivery System Sales 2017-2022 (K Units)
Figure 37. Europe Intranasal Drug Delivery System Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Intranasal Drug Delivery System Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Intranasal Drug Delivery System Revenue 2017-2022 ($ Millions)
Figure 40. Americas Intranasal Drug Delivery System Sales Market Share by Country in 2021
Figure 41. Americas Intranasal Drug Delivery System Revenue Market Share by Country in 2021
Figure 42. United States Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Intranasal Drug Delivery System Sales Market Share by Region in 2021
Figure 47. APAC Intranasal Drug Delivery System Revenue Market Share by Regions in 2021
Figure 48. China Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Intranasal Drug Delivery System Sales Market Share by Country in 2021
Figure 55. Europe Intranasal Drug Delivery System Revenue Market Share by Country in 2021
Figure 56. Germany Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Intranasal Drug Delivery System Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Intranasal Drug Delivery System Revenue Market Share by Country in 2021
Figure 63. Egypt Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Intranasal Drug Delivery System Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Intranasal Drug Delivery System in 2021
Figure 69. Manufacturing Process Analysis of Intranasal Drug Delivery System
Figure 70. Industry Chain Structure of Intranasal Drug Delivery System
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.